Phuong N. Huynh

Array ( [id] => 6990947 [patent_doc_number] => 20050089984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Interleukin-1 beta converting enzyme like apoptotic protease 6' [patent_app_type] => utility [patent_app_number] => 10/961148 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22267 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089984.pdf [firstpage_image] =>[orig_patent_app_number] => 10961148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045578 [patent_doc_number] => 20070264251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'C1q Related Protein' [patent_app_type] => utility [patent_app_number] => 10/570123 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24698 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264251.pdf [firstpage_image] =>[orig_patent_app_number] => 10570123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216677 [patent_doc_number] => 20050260191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84' [patent_app_type] => utility [patent_app_number] => 10/954695 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4705 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260191.pdf [firstpage_image] =>[orig_patent_app_number] => 10954695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7218125 [patent_doc_number] => 20050054833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics' [patent_app_type] => utility [patent_app_number] => 10/951140 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22022 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054833.pdf [firstpage_image] =>[orig_patent_app_number] => 10951140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252126 [patent_doc_number] => 20050142539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Targeted ligands' [patent_app_type] => utility [patent_app_number] => 10/943918 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91111 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142539.pdf [firstpage_image] =>[orig_patent_app_number] => 10943918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004534 [patent_doc_number] => 20070202102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'High-Yield Method For The Production Of Human Antibodies Blocking The Biological Activity Of A Human Cytokine' [patent_app_type] => utility [patent_app_number] => 10/572361 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11116 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202102.pdf [firstpage_image] =>[orig_patent_app_number] => 10572361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142699 [patent_doc_number] => 20050118136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Recombinant production of polyanionic polymers, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/939988 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15052 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118136.pdf [firstpage_image] =>[orig_patent_app_number] => 10939988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246953 [patent_doc_number] => 20070243187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Methods and Materials for Treating Autoimmune Diseases and Conditions' [patent_app_type] => utility [patent_app_number] => 10/571379 [patent_app_country] => US [patent_app_date] => 2004-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7770 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243187.pdf [firstpage_image] =>[orig_patent_app_number] => 10571379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4970742 [patent_doc_number] => 20070110744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Lymphatic and blood endothelial cell genes' [patent_app_type] => utility [patent_app_number] => 10/570963 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35460 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110744.pdf [firstpage_image] =>[orig_patent_app_number] => 10570963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 744381 [patent_doc_number] => 07026140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Serum paraoxonase' [patent_app_type] => utility [patent_app_number] => 10/932269 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7174 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026140.pdf [firstpage_image] =>[orig_patent_app_number] => 10932269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103411 [patent_doc_number] => 20050106137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Chimeric peptide immunogens' [patent_app_type] => utility [patent_app_number] => 10/931566 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14486 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106137.pdf [firstpage_image] =>[orig_patent_app_number] => 10931566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939158 [patent_doc_number] => 20050112721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Chimeric peptide immunogens' [patent_app_type] => utility [patent_app_number] => 10/886469 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5258 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112721.pdf [firstpage_image] =>[orig_patent_app_number] => 10886469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64344 [patent_doc_number] => 07759472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Combination therapy for the treatment of ocular neovascular disorders' [patent_app_type] => utility [patent_app_number] => 10/926806 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 24 [patent_no_of_words] => 31483 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759472.pdf [firstpage_image] =>[orig_patent_app_number] => 10926806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211839 [patent_doc_number] => 20050054051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Albumin fusion proteins' [patent_app_type] => utility [patent_app_number] => 10/922142 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 142517 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054051.pdf [firstpage_image] =>[orig_patent_app_number] => 10922142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 887165 [patent_doc_number] => 07348001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Tie1-binding ligands' [patent_app_type] => utility [patent_app_number] => 10/916840 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 62296 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348001.pdf [firstpage_image] =>[orig_patent_app_number] => 10916840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116238 [patent_doc_number] => 20050069539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Modified human IGF-IR antibodies' [patent_app_type] => utility [patent_app_number] => 10/917073 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22451 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069539.pdf [firstpage_image] =>[orig_patent_app_number] => 10917073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 288905 [patent_doc_number] => 07547518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Method of screening endothelial cells for angiogenic capability' [patent_app_type] => utility [patent_app_number] => 10/913209 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3122 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547518.pdf [firstpage_image] =>[orig_patent_app_number] => 10913209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010278 [patent_doc_number] => 20050063994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods and reagents for decreasing clinical reaction to allergy' [patent_app_type] => utility [patent_app_number] => 10/899551 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 51662 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063994.pdf [firstpage_image] =>[orig_patent_app_number] => 10899551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056353 [patent_doc_number] => 20070059275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Antibody toxin conjugates' [patent_app_type] => utility [patent_app_number] => 10/565331 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 31519 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059275.pdf [firstpage_image] =>[orig_patent_app_number] => 10565331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083803 [patent_doc_number] => 20050049183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Inhibition of protein binding to mast cells' [patent_app_type] => utility [patent_app_number] => 10/888552 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3369 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049183.pdf [firstpage_image] =>[orig_patent_app_number] => 10888552 [rel_patent_id] =>[rel_patent_doc_number] =>)